Who is underrepresented in clinical trials?

Compared with U.S. census data, white Americans were overrepresented in vaccine clinical trials, accounting for 77.9\% of adult participants, while those underrepresented included Black or African American individuals at 10.6\%, American Indian or Alaska Native individuals 0.4\% and Hispanic of Latino individuals at 11.6\% …

Who is underrepresented in research?

NIH considers the following groups as underrepresented in biomedical research: Individuals from racial and ethnic groups such as Blacks or African Americans, Hispanics or Latinos, American Indians or Alaska Natives, Native Hawaiians, and other Pacific Islanders. Individuals with disabilities.

Why are minorities underrepresented in clinical trials?

This is often not the case—people from racial and ethnic minority and other diverse groups are underrepresented in clinical research. This is a concern because people of different ages, races, and ethnicities may react differently to certain medical products. The FDA encourages diverse participation in clinical trials.

Why ethnic diversity in clinical trials is important?

Racial and ethnic minority participation helps researchers find better treatments and better ways to fight diseases like cancer, diabetes, and heart disease, among other conditions that disproportionately impact diverse communities,” she continued.

What are the effects of underrepresentation?

Evidence has been provided that exclusion or underrepresentation of women in clinical studies results in some important information deficits, particularly for the leading causes of morbidity and mortality in women, and that these deficits may adversely affect women’s health.

Who is underrepresented in biomedical research?

The following racial and ethnic groups have been shown to be underrepresented in biomedical research: Blacks or African Americans, Hispanics or Latinos, American Indians or Alaska Natives, Native Hawaiians, and other Pacific Islanders.

How many minorities participate in clinical trials?

The need for diverse voices Statistics from a panel discussion at the BIO Conference in 2019 revealed that racial and ethnic minorities make up 39\% of the population in the U.S., but estimated rates of clinical trial participation for this group range from 2\% to 16\%.

Who are participants of clinical trial?

People who participate in clinical trials do so freely and of their own will. They are volunteers. In many studies, the volunteers will have a common health condition, such as kidney disease, high blood pressure, or diabetes.

How do you include diversity in clinical trials?

1. Widen eligibility criteria. We must map out wider eligibility criteria earlier in the drug development process.
2. Tap into community-based medical centers.
3. Use technology.
4. Connect with patient advocacy groups.
5. Support diversity-focused public policy.
6. Make diversity an internal mandate.
7. About The Authors: